These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. B lymphocytes are required for development and treatment of autoimmune diseases. Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517 [TBL] [Abstract][Full Text] [Related]
15. Design of effective immunotherapy for human autoimmunity. Feldmann M; Steinman L Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214 [TBL] [Abstract][Full Text] [Related]
16. [Autoimmunity]. Müller C Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931 [TBL] [Abstract][Full Text] [Related]
17. Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease? Tarner IH; Fathman CG Nat Clin Pract Rheumatol; 2006 Sep; 2(9):491-9. PubMed ID: 16951704 [TBL] [Abstract][Full Text] [Related]
18. T cell tolerance: models for clinical application to allergy and autoimmunity. Schad VC Chem Immunol; 1994; 58():193-205. PubMed ID: 8011152 [No Abstract] [Full Text] [Related]
20. Despite epitope spreading in the pathogenesis of autoimmune disease, highly restricted approaches to immune therapy may still succeed [with a hedge on this bet]. Steinman L J Autoimmun; 2000 Jun; 14(4):278-82. PubMed ID: 10882053 [No Abstract] [Full Text] [Related] [Next] [New Search]